Update on Positron Emission Tomography/Magnetic Resonance Imaging: Cancer and Inflammation Imaging in the Clinic
P Sabeghi, S Katal, M Chen, F Taravat… - Magnetic …, 2023 - mri.theclinics.com
Multimodal molecular imaging has revolutionized both clinical practice and biomedical
research. PET/CT performed using the positron emission tomography (PET) radiotracer 18F …
research. PET/CT performed using the positron emission tomography (PET) radiotracer 18F …
Achieving safe and high-performance gastrointestinal tract spectral CT imaging with small-molecule lanthanide complex
X Che, C Yang, L Pan, D Gu, G Dai, J Shu… - Biomaterials …, 2023 - spj.science.org
Background Non-intrusive imaging of gastrointestinal (GI) tract using computed tomography
(CT) contrast agents is of the most significant issues in the diagnosis and treatment of GI …
(CT) contrast agents is of the most significant issues in the diagnosis and treatment of GI …
18 F-FDG-PET/MRI in patients with Graves' orbitopathy.
Purpose Currently, therapeutic management of patients with Graves' orbitopathy (GO) relies
on clinical assessments and MRI. However, monitoring of inflammation remains difficult …
on clinical assessments and MRI. However, monitoring of inflammation remains difficult …
Aging Muscles, Myositis, Pain, and Peripheral Neuropathies: PET Manifestations in the Elderly
S Katal, K Taubman, J Han, A Gholamrezanezhad - PET clinics, 2023 - pet.theclinics.com
Advancing age significantly affects the structural and functional characteristics of organs and
tissues, including the peripheral nervous system (PNS) and musculoskeletal system. PET …
tissues, including the peripheral nervous system (PNS) and musculoskeletal system. PET …
Theranostic agents in musculoskeletal disorders
Rheumatoid arthritis (RA) is a chronic autoimmune joint and soft tissue disease that affects
approximately 0.5% to 1% of the world population. 1 It is a systemic inflammatory disease …
approximately 0.5% to 1% of the world population. 1 It is a systemic inflammatory disease …